共 50 条
- [43] Current practice of pressurized intraperitoneal aerosol chemotherapy (PIPAC): Still standardized or on the verge of diversification? EJSO, 2021, 47 (01): : 149 - 156
- [44] Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastases of pancreas and biliary tract cancer Clinical & Experimental Metastasis, 2018, 35 : 635 - 640
- [46] Peritoneal metastasis from pancreatic cancer treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) Clinical & Experimental Metastasis, 2017, 34 : 309 - 314
- [47] Oncological Outcomes After Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) in the Treatment of Peritoneal Carcinomatosis Journal of Gastrointestinal Cancer, 2023, 54 : 632 - 641
- [48] Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter study EJSO, 2019, 45 (12): : 2386 - 2391
- [49] Pressurized intraperitoneal aerosol chemotherapy (PIPAC) might increase the risk of anastomotic leakage compared to HIPEC: an experimental study SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2020, 34 (07): : 2939 - 2946
- [50] Pressurized intraperitoneal aerosol chemotherapy (PIPAC) might increase the risk of anastomotic leakage compared to HIPEC: an experimental study Surgical Endoscopy, 2020, 34 : 2939 - 2946